BIOTECH Patent News provides information about biotechnology that's
patented and patent pending, business news of companies seeking and
receiving patent protection, joint ventures and agreements regarding
research and marketing of patented technology, litigation news concerning
patented products, and legislative activity relating to patented
biotechnology.
The newsletter provides readers with information necessary to recognize
research, licensing and product development activities of small and large
biotechnology companies, and make informed decisions about biotechnology
product and investment strategies.
The newsletter reports on established drug companies like Glaxo, Lilly,
Merck, and SmithKline, growing biotech companies such as Amgen, Centocor,
Genentech, Chiron, Biogen, Xoma and Mycogen, leading research institutions
like Scripps, Salk Institute, Dana Farber, and Sloan-Kettering, and
research schools such as Johns Hopkins, Harvard, Michigan, Wisconsin, MIT,
California and Texas.
For $145 ($165 outside North America), BIOTECH Patent News provides a
year's worth of conveniently organized and concisely written patent
information. Every month, you'll receive briefings on patent and related
business activities of research institutions and companies engaged in
research, development, marketing and licensing of biotechnology products
and processes.
Please let me know if you would like a free issue of the newsletter for
your examination. Just e-mail your response to
"richardparr@compuserve.com", fax your request to United States fax number
908-549-1356 or call me at the same number.
Richard S. Parr
BIOTECH Patent News
P.O. Box 4482
Metuchen, NJ 08840
phone & fax: 908-549-1356